These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
3765 related items for PubMed ID: 16750450
1. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee. Kivitz A, Ma C, Ahdieh H, Galer BS. Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450 [Abstract] [Full Text] [Related]
2. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- and active-controlled phase III trial. Matsumoto AK, Babul N, Ahdieh H. Pain Med; 2005 Mar; 6(5):357-66. PubMed ID: 16266356 [Abstract] [Full Text] [Related]
3. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients. Vorsanger G, Xiang J, Jordan D, Farrell J. Clin Ther; 2007 Mar; 29 Suppl():2520-35. PubMed ID: 18164919 [Abstract] [Full Text] [Related]
4. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. Babul N, Noveck R, Chipman H, Roth SH, Gana T, Albert K. J Pain Symptom Manage; 2004 Jul; 28(1):59-71. PubMed ID: 15223085 [Abstract] [Full Text] [Related]
5. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. Aqua K, Gimbel JS, Singla N, Ma T, Ahdieh H, Kerwin R. Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717 [Abstract] [Full Text] [Related]
6. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. Peniston JH, Gould E. Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907 [Abstract] [Full Text] [Related]
7. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial. DeLemos BP, Xiang J, Benson C, Gana TJ, Pascual ML, Rosanna R, Fleming B. Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961 [Abstract] [Full Text] [Related]
8. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis. Temple AR, Benson GD, Zinsenheim JR, Schweinle JE. Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643 [Abstract] [Full Text] [Related]
9. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study. Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F. Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689 [Abstract] [Full Text] [Related]
10. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. Peloso PM, Bellamy N, Bensen W, Thomson GT, Harsanyi Z, Babul N, Darke AC. J Rheumatol; 2000 Mar; 27(3):764-71. PubMed ID: 10743822 [Abstract] [Full Text] [Related]
11. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study. Hartrick C, Van Hove I, Stegmann JU, Oh C, Upmalis D. Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899 [Abstract] [Full Text] [Related]
12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [Abstract] [Full Text] [Related]
13. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days. Riff DS, Duckor S, Gottlieb I, Diamond E, Soulier S, Raymond G, Boesing SE. Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878 [Abstract] [Full Text] [Related]
14. A 2-week, multicenter, randomized, double-blind, double-dummy, add-on study of the effects of titration on tolerability of tramadol/acetaminophen combination tablet in Korean adults with knee osteoarthritis pain. Choi CB, Song JS, Kang YM, Suh CH, Lee J, Choe JY, Lee CK, Shim SC, Chung WT, Song GG, Kim HA, Ji JD, Nam EJ, Park SH, Hong YH, Sheen DH, Lim MK, Seo YI, Sung YK, Kim TH, Lee JT, Bae SC. Clin Ther; 2007 Jul; 29(7):1381-9. PubMed ID: 17825689 [Abstract] [Full Text] [Related]
15. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM, Messina J, Xie F, Hale M. Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [Abstract] [Full Text] [Related]
16. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Sorge J, Sittl R. Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693 [Abstract] [Full Text] [Related]
17. Efficacy of oxymorphone extended release in postsurgical pain: a randomized clinical trial in knee arthroplasty. Ahdieh H, Ma T, Babul N, Lee D. J Clin Pharmacol; 2004 Jul; 44(7):767-76. PubMed ID: 15199081 [Abstract] [Full Text] [Related]
18. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain. Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA. Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582 [Abstract] [Full Text] [Related]
19. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain. Nicholson B, Ross E, Sasaki J, Weil A. Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075 [Abstract] [Full Text] [Related]
20. A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study. Mehlisch DR, Aspley S, Daniels SE, Southerden KA, Christensen KS. Clin Ther; 2010 Jun; 32(6):1033-49. PubMed ID: 20637958 [Abstract] [Full Text] [Related] Page: [Next] [New Search]